Because of the involvement of the Nrf2-autophagy signaling axis in tumorigenesis and cancer resistance, significant efforts have been made to identify Nrf2-p62 and other autophagy-related markers for predicting cancer risk, establishing preventive measures, and facilitating timely diagnosis and prognosis assessment of cancer (Table 3). This evidence concerns the gene NFE2L2 and cancer.